NCT04403971View on ClinicalTrials.gov

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

May 25, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

December 31, 2020

Conditions
Hospital-acquired Pneumonia
Interventions
DRUG

0.12% Chlorhexidine Oral Liquid Product

The intervention group 1 received 10ml 0.12% chlorhexidine solution for oral rinse twice a day.

DRUG

Listerine Oral Liquid Product

The intervention group 2 received 10ml Listerine solution for oral rinse twice a day.

OTHER

Normal Saline Product

The control group received 10ml normal saline for oral rinse twice a day.

Trial Locations (1)

722

Yen-Chin Chen, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT04403971 - 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia | Biotech Hunter | Biotech Hunter